Related Experiment Videos
Apnea testing for the determination of brain death: a modified protocol. Technical note
E C Benzel1, J P Mashburn, S Conrad
1Division of Neurosurgery, University of New Mexico, Albuquerque.
Journal of Neurosurgery
|June 1, 1992
Summary
The apnea test for brain death determination is refined for better accuracy. This study improves the test by standardizing carbon dioxide levels, ensuring a safer and more efficient brain death diagnosis.
Area of Science:
- Neurology
- Critical Care Medicine
- Physiology
Background:
- The traditional apnea test for brain death relies on achieving a PaCO2 of 60 mm Hg or higher.
- Variability in PaCO2 elevation rates and nonlinear relationships complicate the standard apnea test.
- Refining the apnea test is crucial for accurate brain death determination.
Purpose of the Study:
- To refine the apnea test for brain death determination.
- To investigate the physiology of hypercapnia in patients meeting brain death criteria.
- To establish a more streamlined and safe apnea testing protocol.
Main Methods:
- Evaluated 11 patients meeting all but respiratory criteria for brain death.
- Modified a previous apnea testing protocol, ensuring baseline PaCO2 was 40 mm Hg or above.
- Grouped patients based on baseline PaCO2 (Group I: 40-45 mm Hg; Group II: 46-51 mm Hg) to analyze PaCO2 increase rates.
Main Results:
- Mean PaCO2 increase rates were 5.1 +/- 1.4 mm Hg/min (Group I) and 6.7 +/- 3.1 mm Hg/min (Group II).
- The modified apnea test procedure did not result in cardiovascular instability or hypoxia.
- The refined protocol demonstrated a consistent and manageable rate of PaCO2 elevation.
Conclusions:
- The modified apnea test provides a more reliable method for detecting brain death.
- This refined protocol enhances patient safety during the apnea test.
- The study contributes to a better understanding of hypercapnia and its role in apnea testing.